Using routine diagnostic data as a method of surveillance of arboviral infection in travellers: a comparative analysis with a focus on dengue.

BACKGROUND In a large part of the developing world, limited infectious disease surveillance is performed. In laboratory information management systems data on diagnostic requests is available and may be amenable to trend analyses. We explored this potential, using DENV diagnostic requests as a model. METHOD Test results and anonymised information provided by clinicians were received for 8942 patients from diagnostic centres in the Netherlands from January 2000 to May 2011. The data were evaluated for completeness of a predefined minimal dataset and trends in DENV positive results by travel destination. Population travel data were obtained from a commercial registry, and dengue case notification data by country from WHO DengueNet. RESULTS Vaccination history was rarely reported (0.4%); travel destination was completed for 42% of requests; trends in diagnostic requests and IgM positive tests for this subset correlated to the WHO DENV notifications for the three main travel destinations, with some discrepancies. Additionally, this approach may provide information on disease outbreaks with other pathogens causing diseases clinically similar to DENV. PCR data proved to be insufficient for trend monitoring by country. CONCLUSION This approach is not straightforward, but shows potential for use as a source of additional information for surveillance of disease.

[1]  J. Gaudart,et al.  Multicenter EuroTravNet/GeoSentinel Study of Travel-related Infectious Diseases in Europe , 2009, Emerging infectious diseases.

[2]  E. Caumes,et al.  Illnesses in travelers returning from the tropics: a prospective study of 622 patients. , 2006, Journal of travel medicine.

[3]  G. Chang,et al.  Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes , 2004, Journal of Virology.

[4]  M. Cetron,et al.  Spectrum of disease and relation to place of exposure among ill returned travelers. , 2006, The New England journal of medicine.

[5]  S. Weaver,et al.  The history and evolution of human dengue emergence. , 2008, Advances in virus research.

[6]  M. Wilson,et al.  The traveller and emerging infections: sentinel, courier, transmitter , 2003, Journal of applied microbiology.

[7]  A. Amarilla,et al.  Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. , 2010, Biologicals : journal of the International Association of Biological Standardization.

[8]  T. van Gool,et al.  Travel-related Dengue Virus Infection, the Netherlands, 2006–2007 , 2011, Emerging infectious diseases.

[9]  H. Doerr,et al.  Cross-reactivity in flavivirus serology: new implications of an old finding? , 2002, Medical Microbiology and Immunology.

[10]  E. Gould,et al.  Impact of climate change and other factors on emerging arbovirus diseases. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  A. Barrett,et al.  Transmission cycles, host range, evolution and emergence of arboviral disease , 2004, Nature Reviews Microbiology.

[12]  Mary E. Wilson,et al.  Etiology of travel-related fever , 2007, Current opinion in infectious diseases.

[13]  Cameron P Simmons,et al.  The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. , 2010, Cell host & microbe.

[14]  M. Koopmans,et al.  Underdiagnosis of chikungunya virus infections in symptomatic dutch travelers returning from the Indian ocean area. , 2013, Journal of travel medicine.

[15]  Mary E. Wilson,et al.  Fever in returned travelers: results from the GeoSentinel Surveillance Network. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Castellanos,et al.  Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. , 2008, Revista de salud publica.

[17]  Robert V. Tauxe,et al.  Public Health Surveillance: A Tool for Targeting and Monitoring Interventions , 2006 .

[18]  N. Karabatsos,et al.  Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.

[19]  C. Lai,et al.  Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. , 1996, Virology.

[20]  K. Henning,et al.  What is syndromic surveillance? , 2004, MMWR supplements.

[21]  R. Allwinn Significant increase in travel-associated dengue fever in Germany , 2011, Medical Microbiology and Immunology.

[22]  H. Doerr,et al.  Dengue in Travellers Is Still Underestimated , 2008, Intervirology.

[23]  P. Desprès,et al.  Chikungunya Virus, Southeastern France , 2011, Emerging infectious diseases.

[24]  Mary E. Wilson,et al.  Dengue and chikungunya infections in travelers , 2010, Current opinion in infectious diseases.

[25]  L. Ng,et al.  Chikungunya: a bending reality. , 2009, Microbes and infection.

[26]  M. Moroni,et al.  Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997-2001. , 2006, Journal of travel medicine.

[27]  K. Leder,et al.  Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  A. Barrett,et al.  Flavivirus-induced antibody cross-reactivity , 2011, The Journal of general virology.

[29]  Timothy S Baker,et al.  Conformational changes of the flavivirus E glycoprotein. , 2004, Structure.

[30]  F. Cobelens,et al.  Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia , 2002, Tropical medicine & international health : TM & IH.

[31]  Natasha L. Tilston,et al.  Pan-European Chikungunya surveillance: designing risk stratified surveillance zones , 2009, International journal of health geographics.

[32]  Eva Harris,et al.  Global spread and persistence of dengue. , 2008, Annual review of microbiology.

[33]  Eli Schwartz,et al.  Dengue in travelers. , 2005, The New England journal of medicine.

[34]  N. Beeching,et al.  Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management. , 2009, The Journal of infection.

[35]  K. Stiasny,et al.  Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites , 2006, Journal of Virology.

[36]  J. Eslava-Schmalbach,et al.  Revista de Salud Pública , 2011 .

[37]  A. M. Kilpatrick,et al.  Globalization, Land Use, and the Invasion of West Nile Virus , 2011, Science.